首页> 外文期刊>The lancet oncology >Decision making in non-AIDS-defining malignancies
【24h】

Decision making in non-AIDS-defining malignancies

机译:非艾滋病定义的恶性肿瘤的决策

获取原文
获取原文并翻译 | 示例
           

摘要

In the era before the widespread use of highly active antiretroviral therapy (HAART), people living with HIV/AIDS were rapidly overwhelmed by rare, often fatal, diseases. Median survival after an AIDS diagnosis was about 19 months, and roughly 40% of patients were diagnosed with Kaposi's sarcoma and 20% with lymphoma. The first 15 years of the epidemic were marked by premature deaths and few successes, yet medical oncologists and haematologists played an important part in the care of HIV-infected patients.
机译:在广泛使用高活性抗逆转录病毒疗法(HAART)之前的时代,艾滋病毒/艾滋病感染者被罕见的,往往致命的疾病迅速淹没。艾滋病诊断后的中位生存期约为19个月,大约40%的患者被诊断出患有卡波西肉瘤,而20%的患者被诊断出患有淋巴瘤。流行的最初15年以过早死亡和很少成功为标志,但是医学肿瘤学家和血液学家在HIV感染患者的护理中起着重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号